Baxter International Inc.

NYSE:BAX   3:59:59 PM EDT
76.26
+1.18 (+1.57%)
Products, Expansion

Baxter Announces $100 Million Investment In Biopharma Solutions Halle/Westfalen Facility

Published: 11/11/2021 17:32 GMT
Baxter International Inc. (BAX) - Baxter Announces $100 Million Investment in Biopharma Solutions Halle/westfalen, Germany Sterile Fill/finish Manufacturing Facility.
Baxter - Investment Will Add a Syringe Filling Line, Additional Liquid and Lyophilized (freeze Dried) Vial Capacity and Expand Manufacturing Footprint.
Baxter International Inc - Construction on New Manufacturing Building is Expected to Begin in 2022 and Be Completed in 2024.
Baxter International - Halle/westfalen Facility is Engaged in Multiple Collaborations to Provide Sterile Manufacturing Services for Covid-19 Vaccines.